EcoDrugPlus

Ensembl ID : ENSSVLG00005004389
Gene Symbol: -
Cross references: -
212 Possible Orthologues:

Ensembl ID : ENSSVLG00005006692
Gene Symbol: -
Cross references: -
220 Possible Orthologues:

Ensembl ID : ENSSVLG00005006750
Gene Symbol: -
Cross references: -
206 Possible Orthologues:

Ensembl ID : ENSSVLG00005006939
Gene Symbol: -
Cross references: -
280 Possible Orthologues:

Ensembl ID : ENSSVLG00005008499
Gene Symbol: -
Cross references: -
134 Possible Orthologues:

Ensembl ID : ENSSVLG00005009087
Gene Symbol: -
Cross references: -
86 Possible Orthologues:

Ensembl ID : ENSSVLG00005009993
Gene Symbol: -
Cross references: -
162 Possible Orthologues:

Ensembl ID : ENSSVLG00005010225
Gene Symbol: -
Cross references: -
187 Possible Orthologues:

Ensembl ID : ENSSVLG00005010538
Gene Symbol: -
Cross references: -
146 Possible Orthologues:

Ensembl ID : ENSSVLG00005012189
Gene Symbol: -
Cross references: -
149 Possible Orthologues:

Ensembl ID : ENSSVLG00005012396
Gene Symbol: -
Cross references: -
420 Possible Orthologues:

Ensembl ID : ENSSVLG00005012427
Gene Symbol: -
Cross references: -
420 Possible Orthologues:

Select Keywords:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).